Your browser doesn't support javascript.
loading
Expression level of Th22 cells and its cytokines in patients with acute lymphoblastic leukemia and its significance / 中国实验血液学杂志
Article in Zh | WPRIM | ID: wpr-284020
Responsible library: WPRO
ABSTRACT
This study was purposed to analyze the expression level of Th22 cells and their cytokines in patients with acute lymphoblastic leukemia (ALL) and evaluate its significance. Forty-eight patients with ALL were selected. According to the treatment, all patients were divided into the newly diagnosed group (n = 26) and complete remission (CR) group (n = 22). The proportion of Th22 cells in peripheral blood was detected by flow cytometry (FCM). The expression levels of cytokines IL-22, IL-6, TNF-α and TGF-β in peripheral blood were measured by ELISA. The expression level of IL-22 mRNA in peripheral blood mononuclear cells was examined by semi-quantitative-reverse transcription PCR (RT-PCR). Meanwhile, 30 healthy individuals were selected as a control group. The parameters of the 3 groups were compared. The results showed that the percentage of Th22 cells and the expression levels of IL-22, IL-6, TNF-α and IL-22 mRNA in newly diagnosed group and the CR group were significantly lower than that in control group, the expression level of TGF-β in above mentioned two group was obviously higher than that in control group (P < 0.05). The percentage of Th22 cells and the expression levels of IL-22, IL-6, TNF-α and IL-22 mRNA in newly diagnosed group were evidently lower than that in CR group (P < 0.05), but the expression level of TGF-β in newly diagnosed group obviously higher than that in CR group. The expression level of IL-22 in newly diagnosed group was positively related with expression level of IL-6 and TNF-α, but it was negatively related with expression level of TGF-β. It is concluded that the decreasing of Th22 cells and down-regulation of IL-22 expression level may be related with pathogenesis of ALL, the decreasing of Th22 cells is risk factor for ALL.
Subject(s)
Full text: 1 Database: WPRIM Main subject: Blood / Remission Induction / RNA, Messenger / Case-Control Studies / Transforming Growth Factor beta / Interleukins / Interleukin-6 / Tumor Necrosis Factor-alpha / T-Lymphocytes, Helper-Inducer / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans Language: Zh Journal: Journal of Experimental Hematology Year: 2013 Document type: Article
Full text: 1 Database: WPRIM Main subject: Blood / Remission Induction / RNA, Messenger / Case-Control Studies / Transforming Growth Factor beta / Interleukins / Interleukin-6 / Tumor Necrosis Factor-alpha / T-Lymphocytes, Helper-Inducer / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans Language: Zh Journal: Journal of Experimental Hematology Year: 2013 Document type: Article